Johns Hopkins Retinal Degenerations and Visual Electrophysiology Conference 2023.

项目摘要/摘要 这项申请寻求支持约翰霍普金斯大学的视网膜变性和视觉的三个两年一次的版本 电生理学会议。这些会议将不断更新早期调查人员、实习生、 临床医生和科学家对遗传性视网膜疾病(IRD)的最新翻译和临床研究。在……里面 此外，会议将解决在解释视觉功能测试方面发现的多个知识差距， 包括电生理学和微视野检查。会议将于9月在巴尔的摩举行，一年两次， 马里兰州。本次会议的具体目标包括：1)了解细胞和分子 选定的IRD的基础，2)审查来自临床电生理学会的建议 关于视觉神经生理学测试的视觉(ISCEV)，3)回顾结构和功能结果 IRDS的测量，包括与超低视力研究对象相关的测量，4)分析数据和 来自当前正在开发的治疗方法的结果，特别是那些处于I期、II期和III期临床试验和大型 动物研究，重点是视网膜干细胞和基因治疗，以及其他治疗方式，以及5) 审查与IRD患者公平获得临床护理和研究有关的方面，以及伦理 由于IRDS而导致视力丧失的人所特有的考虑。所申请的资金将用于支持出席 实习生和早期职业调查人员、旅行奖和多样性奖，以支持妇女，在以下方面- 有代表性的少数群体和国际参与者，包括来自发展中国家的参与者。这些 会议将是不同背景的实习生、早期调查人员、以下人员的理想机会- 代表少数族裔和国际受训人员与视网膜领域的领导人建立网络并向其学习 退化。此外，我们希望这次会议将鼓励多学科和国际合作。 临床医生和研究人员之间的合作，以开发新的疗法和临床试验终点。

Project Summary/Abstract This application seeks to support three biennial editions of the Johns Hopkins Retinal Degenerations and Visual Electrophysiology Conference. These meetings will continuously update early-stage investigators, trainees, clinicians, and scientists on the latest translational and clinical research on Inherited retinal diseases (IRDs). In addition, the conference will address multiple identified gaps in knowledge in interpreting visual function tests, including electrophysiology and microperimetry. The meetings will be held biannually in September in Baltimore, Maryland. The specific aims covered by this conference include 1) understanding the cellular and molecular basis of selected IRDs, 2) reviewing the recommendations from the Society of Clinical Electrophysiology of Vision (ISCEV) regarding visual neurophysiology testing, 3) reviewing the structural and functional outcome measures of IRDs, including those relevant to research subjects with ultra-low vision, 4) analyzing data and results from current treatments in development, especially those in Phase I, II, and III clinical trials and large animal studies, with an emphasis on retinal stem cells and gene therapy, and other treatment modalities, and 5) reviewing aspects relating to equitable access to clinical care and research for IRD patients, and ethical considerations unique to people with vision loss due to IRDs. The requested funds will support the attendance of trainees and early-career investigators, travel awards, and diversity awards to support women, under- represented minorities (URMs), and international participants, including those from developing countries. These meetings will be an ideal opportunity for trainees of diverse backgrounds, early-stage investigators, under- represented minorities, and international trainees to network and learn from leaders in the field of retinal degeneration. In addition, we hope this meeting will encourage multidisciplinary and international collaboration between clinicians and investigators to develop novel therapies and clinical trials end points.